_id
690db267ccc777a4e85d0c66
Capt
Ticker
ATHA
Name
Athira Pharma Inc
Exchange
NASDAQ
Address
18706 North Creek Parkway, Bothell, WA, United States, 98011
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.athira.com
Description
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Last Close
6.34
Volume
77399
Current Price
6.1
Change
-0.235
Last Updated
2026-01-20T15:51:28.046Z
Image
data:image/webp;base64,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
Ipo Date
2020-09-18T00:00:00.000Z
Market Cap
26621540
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.991
Sentiment Sources
1
Rating
3
Target Price
4
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
243000
Gross Profit
-243000
Operating Expenses
6631000
Operating Income
-6874000
Interest Expense
-
Pretax Income
-6611000
Net Income
-6611000
Eps
-1.67626506540375
Dividends Per Share
-
Shares Outstanding
3943887
Income Tax Expense
-
EBITDA
-6503000
Operating Margin
-
Total Other Income Expense Net
263000
Cash
20874000
Short Term Investments
4352000
Receivables
-
Inventories
-
Total Current Assets
27025000
Property Plant Equipment
2322000
Total Assets
30033000
Payables
266000
Short Term Debt
452000
Long Term Debt
-
Total Liabilities
3247000
Equity
26786000
Bs_currency_symbol
USD
Depreciation
243000
Change In Working Capital
291000
Cash From Operations
-4668000
Capital Expenditures
0
Cash From Investing
5654000
Cash From Financing
0
Net Change In Cash
986000
Cf_currency_symbol
USD
PE
-
PB
0.8981449525871723
ROE
-24.680803404763683
ROA
-22.012452968401426
FCF
-4668000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
4.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
243000
Quarters > 0 > income Statement > gross Profit
-243000
Quarters > 0 > income Statement > operating Expenses
6631000
Quarters > 0 > income Statement > operating Income
-6874000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-6611000
Quarters > 0 > income Statement > net Income
-6611000
Quarters > 0 > income Statement > eps
-1.67626506540375
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3943887
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6503000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
263000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
20874000
Quarters > 0 > balance Sheet > short Term Investments
4352000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
27025000
Quarters > 0 > balance Sheet > property Plant Equipment
2322000
Quarters > 0 > balance Sheet > total Assets
30033000
Quarters > 0 > balance Sheet > payables
266000
Quarters > 0 > balance Sheet > short Term Debt
452000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3247000
Quarters > 0 > balance Sheet > equity
26786000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6611000
Quarters > 0 > cash Flow > depreciation
243000
Quarters > 0 > cash Flow > change In Working Capital
291000
Quarters > 0 > cash Flow > cash From Operations
-4668000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
5654000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
986000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.67626506540375
Quarters > 0 > ratios > PB
0.8981449525871723
Quarters > 0 > ratios > ROE
-24.680803404763683
Quarters > 0 > ratios > ROA
-22.012452968401426
Quarters > 0 > ratios > FCF
-4668000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
200000
Quarters > 1 > income Statement > gross Profit
-200000
Quarters > 1 > income Statement > operating Expenses
7091000
Quarters > 1 > income Statement > operating Income
-7291000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6966000
Quarters > 1 > income Statement > net Income
-6966000
Quarters > 1 > income Statement > eps
-1.7819065120676458
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3909296
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6766000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
325000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
19888000
Quarters > 1 > balance Sheet > short Term Investments
9935000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
32218000
Quarters > 1 > balance Sheet > property Plant Equipment
2634000
Quarters > 1 > balance Sheet > total Assets
35545000
Quarters > 1 > balance Sheet > payables
171000
Quarters > 1 > balance Sheet > short Term Debt
439000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3559000
Quarters > 1 > balance Sheet > equity
31986000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6966000
Quarters > 1 > cash Flow > depreciation
116000
Quarters > 1 > cash Flow > change In Working Capital
-1813000
Quarters > 1 > cash Flow > cash From Operations
-6999000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
441000
Quarters > 1 > cash Flow > cash From Financing
24000
Quarters > 1 > cash Flow > net Change In Cash
-6534000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.7819065120676458
Quarters > 1 > ratios > PB
0.7455357218783217
Quarters > 1 > ratios > ROE
-21.778277996623522
Quarters > 1 > ratios > ROA
-19.59769306512871
Quarters > 1 > ratios > FCF
-6999000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
243000
Quarters > 2 > income Statement > gross Profit
-243000
Quarters > 2 > income Statement > operating Expenses
9293000
Quarters > 2 > income Statement > operating Income
-9536000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-9143000
Quarters > 2 > income Statement > net Income
-9143000
Quarters > 2 > income Statement > eps
-2.3418100042389756
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3904245
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8900000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
393000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
26422000
Quarters > 2 > balance Sheet > short Term Investments
10248000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
39853000
Quarters > 2 > balance Sheet > property Plant Equipment
2944000
Quarters > 2 > balance Sheet > total Assets
43513000
Quarters > 2 > balance Sheet > payables
867000
Quarters > 2 > balance Sheet > short Term Debt
426000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6183000
Quarters > 2 > balance Sheet > equity
37330000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-9143000
Quarters > 2 > cash Flow > depreciation
243000
Quarters > 2 > cash Flow > change In Working Capital
-7402000
Quarters > 2 > cash Flow > cash From Operations
-14665000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-7351000
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-22016000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.3418100042389756
Quarters > 2 > ratios > PB
0.6379827082775248
Quarters > 2 > ratios > ROE
-24.49236538976694
Quarters > 2 > ratios > ROA
-21.01211132305288
Quarters > 2 > ratios > FCF
-14665000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
968000
Quarters > 3 > income Statement > cost Of Revenue
484000
Quarters > 3 > income Statement > gross Profit
484000
Quarters > 3 > income Statement > operating Expenses
15566000
Quarters > 3 > income Statement > operating Income
-15566000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-15003000
Quarters > 3 > income Statement > net Income
-15003000
Quarters > 3 > income Statement > eps
-3.8988193617193785
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3848088
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-15323000
Quarters > 3 > income Statement > operating Margin
-1608.0578512396694
Quarters > 3 > income Statement > total Other Income Expense Net
563000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
48438000
Quarters > 3 > balance Sheet > short Term Investments
2837000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
54841000
Quarters > 3 > balance Sheet > property Plant Equipment
3252000
Quarters > 3 > balance Sheet > total Assets
58779000
Quarters > 3 > balance Sheet > payables
319000
Quarters > 3 > balance Sheet > short Term Debt
414000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
13938000
Quarters > 3 > balance Sheet > equity
44841000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-15003000
Quarters > 3 > cash Flow > depreciation
243000
Quarters > 3 > cash Flow > change In Working Capital
-13518000
Quarters > 3 > cash Flow > cash From Operations
-26013000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-2812000
Quarters > 3 > cash Flow > cash From Financing
34000
Quarters > 3 > cash Flow > net Change In Cash
-28791000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-3.8988193617193785
Quarters > 3 > ratios > PB
0.5234793336455476
Quarters > 3 > ratios > ROE
-33.45821904061015
Quarters > 3 > ratios > ROA
-25.524421987444494
Quarters > 3 > ratios > FCF
-26013000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-26.87293388429752
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
970000
Annuals > 0 > income Statement > gross Profit
-970000
Annuals > 0 > income Statement > operating Expenses
100902000
Annuals > 0 > income Statement > operating Income
-100902000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-96940000
Annuals > 0 > income Statement > net Income
-96940000
Annuals > 0 > income Statement > eps
-25.191731582022033
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3848088
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-95805000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3962000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
48438000
Annuals > 0 > balance Sheet > short Term Investments
2837000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
54841000
Annuals > 0 > balance Sheet > property Plant Equipment
3252000
Annuals > 0 > balance Sheet > total Assets
58779000
Annuals > 0 > balance Sheet > payables
319000
Annuals > 0 > balance Sheet > short Term Debt
414000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
13938000
Annuals > 0 > balance Sheet > equity
44841000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-96940000
Annuals > 0 > cash Flow > depreciation
455000
Annuals > 0 > cash Flow > change In Working Capital
-11982000
Annuals > 0 > cash Flow > cash From Operations
-97170000
Annuals > 0 > cash Flow > capital Expenditures
33000
Annuals > 0 > cash Flow > cash From Investing
54830000
Annuals > 0 > cash Flow > cash From Financing
194000
Annuals > 0 > cash Flow > net Change In Cash
-42146000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-25.191731582022033
Annuals > 0 > ratios > PB
0.5234793336455476
Annuals > 0 > ratios > ROE
-216.18607970384244
Annuals > 0 > ratios > ROA
-164.9228465948723
Annuals > 0 > ratios > FCF
-97203000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
969000
Annuals > 1 > income Statement > gross Profit
-969000
Annuals > 1 > income Statement > operating Expenses
125466000
Annuals > 1 > income Statement > operating Income
-125466000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-117672000
Annuals > 1 > income Statement > net Income
-117672000
Annuals > 1 > income Statement > eps
-30.94987977437245
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3802018
Annuals > 1 > income Statement > income Tax Expense
-1628000
Annuals > 1 > income Statement > EBITDA
-125968000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
7794000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
90584000
Annuals > 1 > balance Sheet > short Term Investments
56835000
Annuals > 1 > balance Sheet > receivables
1628000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
154729000
Annuals > 1 > balance Sheet > property Plant Equipment
4437000
Annuals > 1 > balance Sheet > total Assets
160245000
Annuals > 1 > balance Sheet > payables
129000
Annuals > 1 > balance Sheet > short Term Debt
368000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
30057000
Annuals > 1 > balance Sheet > equity
130188000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-117672000
Annuals > 1 > cash Flow > depreciation
969000
Annuals > 1 > cash Flow > change In Working Capital
6527000
Annuals > 1 > cash Flow > cash From Operations
-100753000
Annuals > 1 > cash Flow > capital Expenditures
304000
Annuals > 1 > cash Flow > cash From Investing
95089000
Annuals > 1 > cash Flow > cash From Financing
493000
Annuals > 1 > cash Flow > net Change In Cash
-5171000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-30.94987977437245
Annuals > 1 > ratios > PB
0.17814475834946386
Annuals > 1 > ratios > ROE
-90.38621071066459
Annuals > 1 > ratios > ROA
-73.43255639801554
Annuals > 1 > ratios > FCF
-101057000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1048000
Annuals > 2 > income Statement > gross Profit
-1048000
Annuals > 2 > income Statement > operating Expenses
104016000
Annuals > 2 > income Statement > operating Income
-104016000
Annuals > 2 > income Statement > interest Expense
24316000
Annuals > 2 > income Statement > pretax Income
-95639000
Annuals > 2 > income Statement > net Income
-95639000
Annuals > 2 > income Statement > eps
-25.346087428484804
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3773324
Annuals > 2 > income Statement > income Tax Expense
-8377000
Annuals > 2 > income Statement > EBITDA
-88010000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
8377000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
95966000
Annuals > 2 > balance Sheet > short Term Investments
104378000
Annuals > 2 > balance Sheet > receivables
1227000
Annuals > 2 > balance Sheet > inventories
-1227000
Annuals > 2 > balance Sheet > total Current Assets
207533000
Annuals > 2 > balance Sheet > property Plant Equipment
5316000
Annuals > 2 > balance Sheet > total Assets
258153000
Annuals > 2 > balance Sheet > payables
2501000
Annuals > 2 > balance Sheet > short Term Debt
326000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
23016000
Annuals > 2 > balance Sheet > equity
235137000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-95639000
Annuals > 2 > cash Flow > depreciation
1048000
Annuals > 2 > cash Flow > change In Working Capital
11938000
Annuals > 2 > cash Flow > cash From Operations
-72469000
Annuals > 2 > cash Flow > capital Expenditures
1141000
Annuals > 2 > cash Flow > cash From Investing
57664000
Annuals > 2 > cash Flow > cash From Financing
654000
Annuals > 2 > cash Flow > net Change In Cash
-14571000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-25.346087428484804
Annuals > 2 > ratios > PB
0.09788878993948208
Annuals > 2 > ratios > ROE
-40.67373488647044
Annuals > 2 > ratios > ROA
-37.047409869341045
Annuals > 2 > ratios > FCF
-73610000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
479000
Annuals > 3 > income Statement > gross Profit
-479000
Annuals > 3 > income Statement > operating Expenses
63543000
Annuals > 3 > income Statement > operating Income
-64022000
Annuals > 3 > income Statement > interest Expense
3000
Annuals > 3 > income Statement > pretax Income
-54853000
Annuals > 3 > income Statement > net Income
-54853000
Annuals > 3 > income Statement > eps
-14.856788124536681
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3692117
Annuals > 3 > income Statement > income Tax Expense
-479000
Annuals > 3 > income Statement > EBITDA
-54371000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
9169000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
110537000
Annuals > 3 > balance Sheet > short Term Investments
143222000
Annuals > 3 > balance Sheet > receivables
2336000
Annuals > 3 > balance Sheet > inventories
-2336000
Annuals > 3 > balance Sheet > total Current Assets
260799000
Annuals > 3 > balance Sheet > property Plant Equipment
5217000
Annuals > 3 > balance Sheet > total Assets
332008000
Annuals > 3 > balance Sheet > payables
567000
Annuals > 3 > balance Sheet > short Term Debt
288000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10924000
Annuals > 3 > balance Sheet > equity
321084000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-54853000
Annuals > 3 > cash Flow > depreciation
479000
Annuals > 3 > cash Flow > change In Working Capital
6005000
Annuals > 3 > cash Flow > cash From Operations
-43098000
Annuals > 3 > cash Flow > capital Expenditures
1573000
Annuals > 3 > cash Flow > cash From Investing
-4079000
Annuals > 3 > cash Flow > cash From Financing
97089000
Annuals > 3 > cash Flow > net Change In Cash
49912000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-14.856788124536681
Annuals > 3 > ratios > PB
0.07014336964781802
Annuals > 3 > ratios > ROE
-17.08369149506048
Annuals > 3 > ratios > ROA
-16.521589841208645
Annuals > 3 > ratios > FCF
-44671000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.67626506540375
Valuation > metrics > PB
0.8981449525871723
Valuation > final Score
70
Valuation > verdict
10.2% Undervalued
Profitability > metrics > ROE
-24.680803404763683
Profitability > metrics > ROA
-24.46253469010176
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.12122004031956993
Risk > metrics > Interest Coverage
-63.648148148148145
Risk > final Score
-195
Risk > verdict
High
Liquidity > metrics > Current Ratio
37.639275766016716
Liquidity > metrics > Quick Ratio
37.639275766016716
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-86
Prev Risks > 1
-97
Prev Risks > 2
-135
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:25:45.027Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.68
Earnings History > 0 > eps Estimate
-0.13
Earnings History > 0 > eps Difference
-1.55
Earnings History > 0 > surprise Percent
-1192.3077
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.78
Earnings History > 1 > eps Estimate
-0.22
Earnings History > 1 > eps Difference
-1.56
Earnings History > 1 > surprise Percent
-709.0909
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.23
Earnings History > 2 > eps Estimate
-0.24
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
4.1667
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.39
Earnings History > 3 > eps Estimate
-0.405
Earnings History > 3 > eps Difference
0.015
Earnings History > 3 > surprise Percent
3.7037
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.75
Earnings History > 4 > eps Estimate
-0.71
Earnings History > 4 > eps Difference
-0.04
Earnings History > 4 > surprise Percent
-5.6338
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.7
Earnings History > 5 > eps Estimate
-0.74
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
5.4054
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.69
Earnings History > 6 > eps Estimate
-0.79
Earnings History > 6 > eps Difference
0.1
Earnings History > 6 > surprise Percent
12.6582
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.71
Earnings History > 7 > eps Estimate
-0.96
Earnings History > 7 > eps Difference
0.25
Earnings History > 7 > surprise Percent
26.0417
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.87
Earnings History > 8 > eps Estimate
-0.81
Earnings History > 8 > eps Difference
-0.06
Earnings History > 8 > surprise Percent
-7.4074
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.78
Earnings History > 9 > eps Estimate
-0.78
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.73
Earnings History > 10 > eps Estimate
-0.62
Earnings History > 10 > eps Difference
-0.11
Earnings History > 10 > surprise Percent
-17.7419
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.53
Earnings History > 11 > eps Estimate
-0.67
Earnings History > 11 > eps Difference
0.14
Earnings History > 11 > surprise Percent
20.8955
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.53
Earnings History > 12 > eps Estimate
-0.63
Earnings History > 12 > eps Difference
0.1
Earnings History > 12 > surprise Percent
15.873
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.65
Earnings History > 13 > eps Estimate
-0.64
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-1.5625
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.56
Earnings History > 14 > eps Estimate
-0.55
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-1.8182
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.45
Earnings History > 15 > eps Estimate
-0.54
Earnings History > 15 > eps Difference
0.09
Earnings History > 15 > surprise Percent
16.6667
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.42
Earnings History > 16 > eps Estimate
-0.5
Earnings History > 16 > eps Difference
0.08
Earnings History > 16 > surprise Percent
16
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.38
Earnings History > 17 > eps Estimate
-0.34
Earnings History > 17 > eps Difference
-0.04
Earnings History > 17 > surprise Percent
-11.7647
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.25
Earnings History > 18 > eps Estimate
-0.3
Earnings History > 18 > eps Difference
0.05
Earnings History > 18 > surprise Percent
16.6667
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.24
Earnings History > 19 > eps Estimate
-0.4
Earnings History > 19 > eps Difference
0.16
Earnings History > 19 > surprise Percent
40
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.12
Earnings History > 20 > eps Estimate
-0.25
Earnings History > 20 > eps Difference
-0.87
Earnings History > 20 > surprise Percent
-348
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-18
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.44
Earnings History > 21 > eps Estimate
-0.44
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABreakout Move: What is the fair value of Pineapple Financial Inc stock now - Fed Meeting & Daily Oversold Stock Bounce Ideas Bộ Nội Vụ
Read more →Queen’s Road Capital Commits US$20 Million Convertible Debenture to ATHA Energy TipRanks
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$4
Analyst Picks
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 5.06% of the total shares of Athira Pharma Inc
1.
Perceptive Advisors LLC(1.3699%)
since
2025/06/30
2.
BML Capital Management LLC(0.8191%)
since
2025/06/30
3.
Vanguard Group Inc(0.3899%)
since
2025/06/30
4.
Propel Bio Management LLC(0.3785%)
since
2025/06/30
5.
Simplify Asset Management Inc.(0.3785%)
since
2025/06/30
6.
Simplify Propel Opportunities ETF(0.3785%)
since
2025/07/31
7.
Vanguard Total Stock Mkt Idx Inv(0.2662%)
since
2025/07/31
8.
TANG CAPITAL MANAGEMENT LLC(0.1521%)
since
2025/06/30
9.
Bank of America Corp(0.1055%)
since
2025/06/30
10.
BlackRock Inc(0.0955%)
since
2025/06/30
11.
Pathstone Holdings LLC(0.0944%)
since
2025/06/30
12.
Vanguard Institutional Extnd Mkt Idx Tr(0.0787%)
since
2025/07/31
13.
Geode Capital Management, LLC(0.0776%)
since
2025/06/30
14.
Renaissance Technologies Corp(0.0611%)
since
2025/06/30
15.
Citadel Advisors Llc(0.0533%)
since
2025/06/30
16.
UBS Group AG(0.0516%)
since
2025/06/30
17.
Qube Research & Technologies(0.0489%)
since
2025/06/30
18.
Fidelity Extended Market Index(0.0416%)
since
2025/07/31
19.
Two Sigma Advisers, LLC(0.0391%)
since
2025/06/30
20.
Laird Norton Tyee Trust Co(0.0323%)
since
2025/06/30
21.
State Street Corp(0.0272%)
since
2025/06/30
22.
Susquehanna International Group, LLP(0.0204%)
since
2025/06/30
23.
Advisor Group Holdings, Inc.(0.0152%)
since
2025/06/30
24.
Northern Trust Corp(0.0136%)
since
2025/06/30
25.
Fidelity Total Market Index(0.0121%)
since
2025/07/31
26.
Fidelity Series Total Market Index(0.01%)
since
2025/07/31
27.
Spartan Extended Market Index Pool F(0.0079%)
since
2025/07/31
28.
NT Ext Equity Mkt Idx Fd - NL(0.0068%)
since
2025/06/30
29.
NT Ext Equity Mkt Idx Fd - L(0.0063%)
since
2025/06/30
30.
Northern Trust Extended Eq Market Idx(0.0063%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0053%)
since
2025/06/30
32.
Spartan Total Market Index Pool G(0.0043%)
since
2025/07/31
33.
Vanguard U.S. Eq Idx £ Acc(0.0034%)
since
2025/07/31
34.
Blackrock US Eq Mkt Fund CF(0.0026%)
since
2025/07/31
35.
U.S. Equity Market Fund F(0.0022%)
since
2025/06/30
36.
State St US Extended Mkt Indx NL Cl C(0.0022%)
since
2025/08/31
37.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0018%)
since
2025/06/30
38.
Fidelity Nasdaq Composite Index(0.0017%)
since
2025/07/31
39.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0015%)
since
2024/12/31
40.
Blackstone Alternative Multi-Strategy I(0.001%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.68
EPS Estimate
-0.13
EPS Difference
-1.55
Surprise Percent
-1192.3077%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.